Literature DB >> 8159215

Turbidimetric and visual criteria for determining the in vitro activity of six antifungal agents against Candida spp. and Cryptococcus neoformans.

F Barchiesi1, M Del Poeta, V Morbiducci, F Ancarani, G Scalise.   

Abstract

The drug concentration which inhibited 50% of growth (IC50), the lowest drug concentration at which growth was less than 30% of that in a positive control well (IC30), the visual minimal inhibitory concentration (MIC), and the minimum fungicidal concentration (MFC), were applied to study the effects of fluconazole, itraconazole, ketoconazole, miconazole, flucytosine, and amphotericin B against 36 isolates of Candida spp. and Cryptococcus neoformans by a broth microdilution technique. When the recommendations established by the NCCLS Subcommittee on Antifungal Susceptibility Tests were applied for the visual reading of the microplates, the results were comparable with those obtained by the turbidimetric methods. Differences between MICs and IC30s were observed with miconazole against strains of C. glabrata (p = 0.014) and with flucytosine against strains of C. neoformans (p = 0.041). Differences between MICs and IC50s were observed with fluconazole against strains of C. albicans (p = 0.027), C. tropicalis (p = 0.046), and C. neoformans (p = 0.041); with miconazole against strains of C. glabrata (p = 0.014); and with amphotericin B against strains of C. parapsilosis (p = 0.025). Ten additional isolates of C. albicans from AIDS patients suffering from recurrent episodes of oral candidiasis and clinically resistant to fluconazole also were included in this study. The MICs of fluconazole of these strains were significantly higher than those of the control group (p = 0.003). When the turbidimetric parameters were applied for testing the in vitro activity of fluconazole against the above isolates, both IC30 and IC50 were capable of discriminating the strains of the two groups (p = 0.002, p = 0.001, respectively).(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8159215     DOI: 10.1007/bf01103052

Source DB:  PubMed          Journal:  Mycopathologia        ISSN: 0301-486X            Impact factor:   2.574


  14 in total

1.  Collaborative comparison of broth macrodilution and microdilution antifungal susceptibility tests.

Authors:  A Espinel-Ingroff; C W Kish; T M Kerkering; R A Fromtling; K Bartizal; J N Galgiani; K Villareal; M A Pfaller; T Gerarden; M G Rinaldi
Journal:  J Clin Microbiol       Date:  1992-12       Impact factor: 5.948

Review 2.  Fungal infections in AIDS patients.

Authors:  B Dupont; J R Graybill; D Armstrong; R Laroche; J E Touzé; L J Wheat
Journal:  J Med Vet Mycol       Date:  1992

3.  In vitro susceptibilities and biotypes of Candida albicans isolates from the oral cavities of patients infected with human immunodeficiency virus.

Authors:  H C Korting; M Ollert; A Georgii; M Fröschl
Journal:  J Clin Microbiol       Date:  1988-12       Impact factor: 5.948

4.  Inhibition and killing of Candida albicans in vitro by five imidazoles in clinical use.

Authors:  E Lefler; D A Stevens
Journal:  Antimicrob Agents Chemother       Date:  1984-04       Impact factor: 5.191

5.  Fluconazole, itraconazole and ketoconazole in-vitro activity. A comparative study.

Authors:  D Arzeni; F Barchiesi; F Ancarani; G Scalise
Journal:  J Chemother       Date:  1991-06       Impact factor: 1.714

6.  Fluconazole and ketoconazole in the treatment of oral and esophageal candidiasis in AIDS patients.

Authors:  F Barchiesi; A Giacometti; D Arzeni; P Branchesi; G Crescenzi; F Ancarani; G Scalise
Journal:  J Chemother       Date:  1992-12       Impact factor: 1.714

7.  Antimicrobial susceptibility testing of yeasts: a turbidimetric technique independent of inoculum size.

Authors:  J N Galgiani; D A Stevens
Journal:  Antimicrob Agents Chemother       Date:  1976-10       Impact factor: 5.191

Review 8.  Emerging fungal pathogens.

Authors:  E J Anaissie; G P Bodey; M G Rinaldi
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1989-04       Impact factor: 3.267

9.  Microtiter broth dilution method for yeast susceptibility testing with validation by clinical outcome.

Authors:  M Radetsky; R C Wheeler; M H Roe; J K Todd
Journal:  J Clin Microbiol       Date:  1986-10       Impact factor: 5.948

10.  Fluconazole susceptibility testing of Candida albicans: microtiter method that is independent of inoculum size, temperature, and time of reading.

Authors:  E Anaissie; V Paetznick; G P Bodey
Journal:  Antimicrob Agents Chemother       Date:  1991-08       Impact factor: 5.191

View more
  8 in total

1.  Influence of incubation time, inoculum size, and glucose concentrations on spectrophotometric endpoint determinations for amphotericin B, fluconazole, and itraconazole.

Authors:  M H Nguyen; C Y Yu
Journal:  J Clin Microbiol       Date:  1999-01       Impact factor: 5.948

2.  In vitro activities of terbinafine in combination with fluconazole and itraconazole against isolates of Candida albicans with reduced susceptibility to azoles.

Authors:  F Barchiesi; L Falconi Di Francesco; G Scalise
Journal:  Antimicrob Agents Chemother       Date:  1997-08       Impact factor: 5.191

3.  Carriage frequency, intensity of carriage, and strains of oral yeast species vary in the progression to oral candidiasis in human immunodeficiency virus-positive individuals.

Authors:  Kaaren G Vargas; Sophie Joly
Journal:  J Clin Microbiol       Date:  2002-02       Impact factor: 5.948

4.  Comparison of visual and spectrophotometric methods of MIC endpoint determinations by using broth microdilution methods to test five antifungal agents, including the new triazole D0870.

Authors:  M A Pfaller; S A Messer; S Coffmann
Journal:  J Clin Microbiol       Date:  1995-05       Impact factor: 5.948

5.  Comparison of a photometric method with standardized methods of antifungal susceptibility testing of yeasts.

Authors:  C J Clancy; M H Nguyen
Journal:  J Clin Microbiol       Date:  1997-11       Impact factor: 5.948

6.  Quantitation of ergosterol content: novel method for determination of fluconazole susceptibility of Candida albicans.

Authors:  B A Arthington-Skaggs; H Jradi; T Desai; C J Morrison
Journal:  J Clin Microbiol       Date:  1999-10       Impact factor: 5.948

7.  Clinical evaluation of the ASTY colorimetric microdilution panel for antifungal susceptibility testing.

Authors:  M A Pfaller; S Arikan; M Lozano-Chiu; Y Chen; S Coffman; S A Messer; R Rennie; C Sand; T Heffner; J H Rex; J Wang; N Yamane
Journal:  J Clin Microbiol       Date:  1998-09       Impact factor: 5.948

8.  Comparison of two alternative microdilution procedures with the National Committee for Clinical Laboratory Standards reference macrodilution method M27-P for in vitro testing of fluconazole-resistant and -susceptible isolates of Candida albicans.

Authors:  A Espinel-Ingroff; J L Rodríguez-Tudela; J V Martínez-Suárez
Journal:  J Clin Microbiol       Date:  1995-12       Impact factor: 5.948

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.